Haemonetics Corporation (HAE)
Gross profit margin
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 748,958 | 691,548 | 615,097 | 505,502 | 397,838 |
| Revenue | US$ in thousands | 1,360,820 | 1,309,060 | 1,168,660 | 993,196 | 870,463 |
| Gross profit margin | 55.04% | 52.83% | 52.63% | 50.90% | 45.70% |
March 31, 2025 calculation
Gross profit margin = Gross profit ÷ Revenue
= $748,958K ÷ $1,360,820K
= 55.04%
The gross profit margin of Haemonetics Corporation has shown a positive trend over the past five years. Starting at 45.70% on March 31, 2021, it increased steadily to reach 55.04% on March 31, 2025. This indicates that the company has been effectively controlling its production costs and improving its pricing strategies. A rising gross profit margin is generally considered a positive signal, as it suggests the company is able to generate more profit from its core operations. Haemonetics' consistent improvement in gross profit margin reflects its operational efficiency and pricing power, which may contribute to its overall financial health and competitiveness in the market.
Peer comparison
Mar 31, 2025